John O. Link

3.8k total citations
36 papers, 2.2k citations indexed

About

John O. Link is a scholar working on Molecular Biology, Organic Chemistry and Hepatology. According to data from OpenAlex, John O. Link has authored 36 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Organic Chemistry and 10 papers in Hepatology. Recurrent topics in John O. Link's work include Hepatitis C virus research (10 papers), Asymmetric Synthesis and Catalysis (8 papers) and Hepatitis B Virus Studies (8 papers). John O. Link is often cited by papers focused on Hepatitis C virus research (10 papers), Asymmetric Synthesis and Catalysis (8 papers) and Hepatitis B Virus Studies (8 papers). John O. Link collaborates with scholars based in United States, Norway and United Kingdom. John O. Link's co-authors include E. J. Corey, John H. Kenten, Jonathan K. Leland, Haresh P. Shah, M.J. Powell, Gary F. Blackburn, David B. Talley, Yang Shao, Diana M. Brainard and Richard Massey and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

John O. Link

36 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John O. Link United States 27 966 747 437 424 275 36 2.2k
Kent D. Stewart United States 34 1.3k 1.3× 967 1.3× 300 0.7× 518 1.2× 57 0.2× 91 3.1k
Christian Périgaud France 28 1.7k 1.8× 952 1.3× 121 0.3× 558 1.3× 243 0.9× 175 3.3k
Carlo Scolastico Italy 36 1.8k 1.8× 2.3k 3.0× 974 2.2× 986 2.3× 85 0.3× 217 4.6k
Pierre L. Beaulieu Canada 32 796 0.8× 1.3k 1.7× 767 1.8× 539 1.3× 38 0.1× 79 2.6k
Nobuo Shimma Japan 26 1.0k 1.1× 807 1.1× 179 0.4× 317 0.7× 49 0.2× 56 3.0k
Peter S. Dragovich United States 27 1.0k 1.1× 876 1.2× 221 0.5× 424 1.0× 57 0.2× 77 2.8k
James A. Kelley United States 35 2.0k 2.1× 863 1.2× 26 0.1× 596 1.4× 154 0.6× 139 3.8k
José Pérez Spain 32 613 0.6× 1.6k 2.2× 77 0.2× 119 0.3× 78 0.3× 165 3.4k
Paul Reichert United States 19 857 0.9× 172 0.2× 264 0.6× 224 0.5× 56 0.2× 46 2.1k
Pierre Falson France 29 1.6k 1.7× 235 0.3× 82 0.2× 235 0.6× 124 0.5× 114 2.6k

Countries citing papers authored by John O. Link

Since Specialization
Citations

This map shows the geographic impact of John O. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John O. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John O. Link more than expected).

Fields of papers citing papers by John O. Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John O. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John O. Link. The network helps show where John O. Link may publish in the future.

Co-authorship network of co-authors of John O. Link

This figure shows the co-authorship network connecting the top 25 collaborators of John O. Link. A scholar is included among the top collaborators of John O. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John O. Link. John O. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Jim, Bing Lu, Gavin Carr, et al.. (2024). Lenacapavir Exhibits Atropisomerism—Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway. Journal of Pharmacology and Experimental Therapeutics. 391(1). 91–103. 6 indexed citations
2.
Cheng, Guofeng, Tian Yang, Brian Doehle, et al.. (2016). In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir. Antimicrobial Agents and Chemotherapy. 60(3). 1847–1853. 50 indexed citations
3.
Kwon, Hyock Joo, Weimei Xing, Anita Niedziela‐Majka, et al.. (2015). Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent. PLoS ONE. 10(4). e0122844–e0122844. 29 indexed citations
4.
Lawitz, Eric, Bradley Freilich, John O. Link, et al.. (2015). A phase 1, randomized, dose‐ranging study of GS‐5816, a once‐daily NS5A inhibitor, in patients with genotype 1–4 hepatitis C virus. Journal of Viral Hepatitis. 22(12). 1011–1019. 38 indexed citations
5.
German, Polina, Phillip S. Pang, Cheng‐Xiong Yang, et al.. (2013). 1195 HEALTHY VOLUNTEER FIRST-IN-HUMAN EVALUATION OF GS-5816, A NOVEL SECOND GENERATION BROAD-GENOTYPIC NS5A INHIBITOR WITH POTENTIAL FOR ONCE-DAILY DOSING. Journal of Hepatology. 58. S486–S486. 9 indexed citations
6.
Appleby, T.C., Thomas Butler, Ruby Cai, et al.. (2012). Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease. Bioorganic & Medicinal Chemistry Letters. 22(7). 2629–2634. 26 indexed citations
7.
Hebner, Christy M., Bin Han, Katherine M. Brendza, et al.. (2012). The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function. PLoS ONE. 7(6). e39163–e39163. 32 indexed citations
8.
Lawitz, Eric, Daniel Gruener, John M. Hill, et al.. (2012). A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C. Journal of Hepatology. 57(1). 24–31. 120 indexed citations
9.
Link, John O., et al.. (2006). Advances in cathepsin S inhibitor design.. PubMed. 9(4). 471–82. 33 indexed citations
10.
Katz, B.A., Kyle Elrod, Christine Luong, et al.. (2001). A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site11Edited by D. Rees. Journal of Molecular Biology. 307(5). 1451–1486. 61 indexed citations
11.
Dhanak, Dashyant, George Burton, Michael G. Darcy, et al.. (2000). Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease. Bioorganic & Medicinal Chemistry Letters. 10(20). 2279–2282. 10 indexed citations
12.
Abraham, Ralph, et al.. (1996). Determination of binding constants of diabodies directed against prostate-specific antigen using electrochemiluminescence-based immunoassays. Journal of Molecular Recognition. 9(5-6). 456–461. 5 indexed citations
13.
Link, John O. & Kenneth Straub. (1996). Trapping of an IMP Dehydrogenase−Substrate Covalent Intermediate by Mycophenolic Acid. Journal of the American Chemical Society. 118(8). 2091–2092. 36 indexed citations
14.
Abraham, Ralph, et al.. (1995). Screening and kinetic analysis of recombinant anti-CEA antibody fragments. Journal of Immunological Methods. 183(1). 119–125. 29 indexed citations
15.
Rohloff, John C., et al.. (1995). General preparation of 3-alkyl-1-naphthols. Tetrahedron Letters. 36(38). 6815–6818. 20 indexed citations
16.
McCafferty, John, Kevin Fitzgerald, J. C. Earnshaw, et al.. (1994). Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display. Applied Biochemistry and Biotechnology. 47(2-3). 157–173. 89 indexed citations
17.
Kenten, John H., et al.. (1992). Rapid, non-separation electrochemiluminescent DNA hybridization assays for PCR products, using 3′-labelled oligonucleotide probes. Molecular and Cellular Probes. 6(6). 495–503. 26 indexed citations
18.
Corey, E. J. & John O. Link. (1992). A general, catalytic, and enantioselective synthesis of .alpha.-amino acids. Journal of the American Chemical Society. 114(5). 1906–1908. 209 indexed citations
19.
Blackburn, Gary F., Haresh P. Shah, John H. Kenten, et al.. (1991). Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics. Clinical Chemistry. 37(9). 1534–1539. 448 indexed citations
20.
Corey, E. J. & John O. Link. (1991). A catalytic enantioselective synthesis of denopamine, a useful drug for congestive heart failure. The Journal of Organic Chemistry. 56(1). 442–444. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kent D. Stewart Breakdown of academic impact, for papers by Christian Périgaud Breakdown of academic impact, for papers by Carlo Scolastico Breakdown of academic impact, for papers by Pierre L. Beaulieu Breakdown of academic impact, for papers by Nobuo Shimma Breakdown of academic impact, for papers by Peter S. Dragovich Breakdown of academic impact, for papers by James A. Kelley Breakdown of academic impact, for papers by José Pérez Breakdown of academic impact, for papers by Paul Reichert Breakdown of academic impact, for papers by Pierre Falson
Rankless by CCL
2026